Bioresorbable Medical Material Sales

Bioresorbable Medical Material Sales Market Outlook

The global bioresorbable medical material market is projected to reach approximately USD 8.2 billion by 2035, expanding at a compound annual growth rate (CAGR) of about 10.4% during the forecast period of 2025 to 2035. The growth of this market can be attributed to the rising prevalence of chronic diseases, increasing demand for minimally invasive surgical procedures, and the growing focus on sustainable and biodegradable materials in the healthcare sector. Additionally, advancements in technology and materials science are facilitating the development of innovative bioresorbable materials that can enhance patient outcomes and reduce the need for additional surgeries. Furthermore, regulatory approvals and increasing investments in research and development are likely to drive market expansion significantly.

Growth Factor of the Market

One of the primary growth factors contributing to the bioresorbable medical material market is the escalating demand for advanced surgical procedures that require innovative materials to improve recovery times and patient well-being. As healthcare providers focus more on enhancing the quality of care and minimizing the risk of complications associated with traditional non-bioresorbable materials, bioresorbable options are becoming increasingly popular. Moreover, the rising prevalence of orthopedic and cardiovascular diseases has intensified the need for bioresorbable implants that can effectively address these conditions while dissolving harmlessly in the body. The ongoing shift towards outpatient surgical procedures, especially in ambulatory surgical centers, is also propelling the demand for bioresorbable materials, which offer less invasive options for treatment. Furthermore, the increasing awareness of environmental concerns is encouraging the adoption of sustainable healthcare solutions, making bioresorbable materials an attractive choice for medical applications.

Key Highlights of the Market

• The market is expected to witness a CAGR of 10.4% from 2025 to 2035.
• North America accounted for the largest market share in 2025.
• Orthopedic applications are projected to dominate the application segment.
• Polylactic Acid (PLA) is anticipated to be the leading product type in the market.
• Growing investments in R&D are driving innovation in bioresorbable materials.

By Product Type

Polylactic Acid:

Polylactic Acid (PLA) is one of the most widely used bioresorbable materials in the medical field, primarily due to its excellent mechanical properties and biocompatibility. PLA is derived from renewable resources, making it an eco-friendly option for medical applications. Its ability to degrade into non-toxic lactic acid over time enhances its suitability for various applications, including sutures, grafts, and implants. The material's processing versatility allows it to be molded into various forms, catering to diverse medical needs. Given the rising demand for biodegradable solutions in the healthcare industry, PLA is expected to maintain a significant market presence in the coming years, supported by ongoing research and development efforts aimed at improving its properties and expanding its application range.

Polyglycolic Acid:

Polyglycolic Acid (PGA) is another prominent bioresorbable material known for its rapid degradation rate and high tensile strength. Often utilized in surgical sutures and meshes, PGA is favored for applications where a quick resorption rate is paramount for patient recovery. The material is highly bio-compatible, reducing the risk of adverse reactions in patients. As the demand for effective and safe surgical solutions increases, the utilization of PGA in the medical field is anticipated to grow. Moreover, ongoing breakthroughs in polymer chemistry and processing techniques are paving the way for enhanced formulations of PGA, increasing its applicability across various medical specialties, particularly in orthopedics and soft tissue repair.

Polycaprolactone:

Polycaprolactone (PCL) has emerged as a favorable bioresorbable polymer due to its unique properties, including slow degradation rates and excellent flexibility. The material is often used in applications such as drug delivery systems, sutures, and implants, primarily for its ability to support cellular growth and tissue regeneration. PCL's mechanical characteristics and biocompatibility make it an attractive candidate for various medical applications, especially in tissue engineering where longer-term support is necessary. As research continues to explore the potential of PCL in complex medical solutions, its adoption is expected to increase significantly in the coming years, particularly in sectors focusing on regenerative medicine and advanced wound care.

Calcium Phosphate:

Calcium Phosphate (CaP) is a naturally occurring mineral that plays a crucial role in bone structure and health, making it an essential bioresorbable material in orthopedic and dental applications. CaP is highly bioactive, promoting osseointegration and facilitating the healing process in bone-related surgeries. Its ability to be resorbed and replaced by natural bone tissues enhances its appeal for hard tissue regeneration. As the trend towards using bioactive materials in orthopedic surgery continues to grow, the demand for calcium phosphate-based products is projected to rise significantly. Additionally, advancements in the synthesis of calcium phosphate compounds are likely to lead to new formulations that can provide enhanced performance in clinical applications.

Others:

This category encompasses various other bioresorbable materials that are being explored for medical applications, including polymer blends and composite materials. These alternatives often combine the advantageous properties of different materials to create customized solutions that meet specific clinical needs. The development of innovative materials, such as hybrid polymers that exhibit improved strength and biodegradability, is likely to drive the growth of this segment. Furthermore, ongoing research into novel bioresorbable composites is paving the way for new applications in areas such as drug delivery, regenerative medicine, and advanced surgical devices, contributing to a diverse and evolving market landscape.

By Application

Orthopedic:

The orthopedic segment is a significant application area for bioresorbable medical materials, driven by the increasing prevalence of fractures and joint disorders. Bioresorbable implants, screws, and pins are commonly used in orthopedic surgeries, providing temporary support to bone structures while allowing for natural healing processes to occur. These materials can eliminate the need for subsequent surgeries to remove non-bioresorbable implants, thereby reducing patient discomfort and healthcare costs. As advancements in material science continue to enhance the performance of bioresorbable options in orthopedic applications, this segment is expected to experience robust growth over the next decade, supported by increasing surgical procedures and innovations in implant design.

Dental:

Bioresorbable materials are gaining traction in the dental field, where they are utilized in procedures such as tooth extractions, periodontal treatments, and bone grafting. The use of bioresorbable membranes and sutures in dental applications helps promote tissue regeneration and healing while minimizing the risk of complications associated with traditional materials. The growing trend towards minimally invasive dental treatments and the rising awareness of patient safety are contributing to the adoption of bioresorbable materials in dental practices. As the demand for effective dental solutions continues to rise, this segment is expected to exhibit strong growth, supported by innovations in product offerings and an increasing focus on patient-centered care.

Cardiovascular:

The cardiovascular application of bioresorbable materials is rapidly evolving, with bioresorbable stents and grafts being developed to address various cardiovascular conditions. These materials offer the advantage of providing temporary support to blood vessels, reducing the risk of complications associated with permanent implants. The ability of bioresorbable cardiovascular devices to dissolve over time and encourage natural vessel healing is propelling their adoption in clinical settings. As cardiovascular diseases continue to be a leading cause of morbidity and mortality globally, the demand for advanced bioresorbable solutions is expected to grow, driven by ongoing research and technological advancements in this area.

Tissue Engineering:

Tissue engineering is a pivotal application area for bioresorbable materials, as these materials are essential for scaffolding in regenerative medicine. They provide a temporary structure for cells to grow and develop into new tissues while gradually degrading and being replaced by the body’s natural tissues. The increasing emphasis on personalized medicine and regenerative therapies is fostering innovations in bioresorbable scaffolds that can cater to specific tissue types and functions. Additionally, the combination of bioresorbable materials with growth factors and cells is propelling the field of tissue engineering forward, leading to new treatment options for various conditions. Given the potential of bioresorbable materials in facilitating tissue regeneration, this segment is anticipated to witness substantial growth in the coming years.

Others:

This category includes a range of applications for bioresorbable materials that are currently under exploration or are emerging in the healthcare industry. Examples include their use in wound healing, drug delivery systems, and aesthetic procedures. The versatility of bioresorbable materials allows for innovative approaches to address various medical challenges, such as providing localized drug delivery while minimizing systemic side effects. As research continues into the potential uses of bioresorbable materials in diverse applications, the growth of this segment is expected to be significant, reflecting the ongoing demand for advanced medical solutions in various healthcare settings.

By User

Hospitals:

Hospitals remain the primary end-user of bioresorbable medical materials due to the increasing number of surgeries performed and the focus on enhancing patient outcomes. Hospitals are adopting bioresorbable materials for various surgical procedures, including orthopedic, cardiovascular, and dental surgeries, leading to improved recovery times and reduced complications. The trend towards minimizing hospital stays and promoting outpatient procedures is further driving the demand for bioresorbable options in surgical settings. Additionally, hospitals are investing in advanced medical technologies and materials to provide better care to patients, thus contributing to the growth of the bioresorbable medical material market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are experiencing significant growth in the use of bioresorbable medical materials, primarily due to the rising trend of outpatient surgeries. ASCs focus on providing same-day surgical services, and the adoption of bioresorbable materials aligns with the goal of minimizing patient recovery times and complications. These centers are increasingly utilizing bioresorbable implants and devices that can dissolve naturally, reducing the need for subsequent procedures to remove traditional implants. The convenience and efficiency of ASCs, combined with the benefits of bioresorbable materials, are propelling growth in this segment, as more patients seek minimally invasive surgical options.

Specialty Clinics:

Specialty clinics play a crucial role in the adoption of bioresorbable medical materials, particularly in fields such as dentistry, orthopedics, and dermatology. These clinics are often at the forefront of adopting advanced technologies and materials that enhance treatment outcomes. Bioresorbable materials are increasingly being employed in specialized procedures, such as dental implants and aesthetic surgeries, where patient safety and comfort are paramount. As patient demand for personalized and minimally invasive treatments continues to rise, specialty clinics are likely to expand their offerings of bioresorbable solutions, driving growth in this segment of the market.

Others:

This category includes various additional end-users of bioresorbable materials, such as research institutions and educational organizations involved in medical training. These entities may utilize bioresorbable materials for experimental applications and advancements in medical technology. The ongoing research and development activities in the field of bioresorbable materials are crucial for discovering new applications and enhancing existing solutions. As awareness of the benefits of bioresorbable materials continues to spread, other end-users may emerge, further contributing to the growth of this market segment.

By Form

Fibers:

Bioresorbable fibers are utilized primarily in surgical sutures and tissue repair applications. Their ability to provide temporary support while gradually degrading makes them an essential component in various surgical procedures. The demand for bioresorbable fibers is driven by the increasing preference for minimally invasive techniques, where the use of traditional sutures may pose higher risks of complications. Fibers can be engineered to provide specific tensile strengths and degradation rates, enabling customization for different surgical needs. As the trend towards patient-centered care continues to rise, the market for bioresorbable fibers is anticipated to witness considerable growth, supported by innovations in fiber technology and production methods.

Films:

Bioresorbable films are gaining traction due to their versatility in applications such as drug delivery, wound healing, and surgical barriers. These films can be designed to release therapeutic agents over a controlled period while providing a protective barrier to promote healing. The bioresorbable nature of films allows for gradual absorption by the body, reducing the need for surgical interventions to remove non-biodegradable materials. The increasing focus on advanced wound care and the development of innovative drug delivery systems are driving the demand for bioresorbable films in the healthcare industry. As manufacturers continue to explore new formulations and applications for bioresorbable films, this segment is expected to grow significantly.

Sponges:

Bioresorbable sponges are utilized in various medical applications, particularly for drug delivery and wound management. These sponges can be designed to absorb fluids and release medications over time, promoting healing and recovery. The use of bioresorbable sponges in surgical settings helps reduce the risk of infection while providing a scaffold for tissue regeneration. The growing demand for effective wound care solutions, along with the increasing prevalence of chronic wounds, is driving the adoption of bioresorbable sponges in clinical practice. As innovations in sponge technology continue to emerge, this segment is likely to experience substantial growth in the coming years.

Meshes:

Bioresorbable meshes are increasingly being used in surgical procedures, particularly in hernia repair and soft tissue reconstruction. These meshes provide structural support during the healing process, allowing for natural tissue regeneration. The bioresorbable nature of these meshes eliminates the need for removal surgeries, reducing the overall burden on patients. As awareness of the benefits of bioresorbable meshes grows, alongside advancements in biomaterial technology, this segment is expected to witness significant growth in the healthcare market. Furthermore, the development of custom-designed meshes tailored to specific clinical needs is likely to enhance their applicability in various surgical scenarios.

Others:

This category encompasses various other forms of bioresorbable materials, including scaffolds and composites designed for specific applications in medical settings. These innovative forms provide enhanced functionality and versatility in addressing diverse medical challenges. The ongoing research into new bioresorbable composite materials is paving the way for exciting developments in areas such as tissue engineering and regenerative medicine. As researchers explore the potential of combining different materials to create customized solutions, the market for alternative forms of bioresorbable materials is expected to grow, reflecting the increasing demand for innovative healthcare solutions.

By Region

The bioresorbable medical material market is witnessing significant growth across various regions, with North America leading the way due to its well-established healthcare infrastructure and the presence of key market players. In 2025, North America is expected to account for approximately 35% of the global market share. The region's focus on advanced research and development activities, coupled with rising healthcare expenditure, is driving the growth of bioresorbable materials. Furthermore, the increasing prevalence of chronic diseases necessitates innovative medical solutions, further fueling demand for bioresorbable products. The CAGR for the North American market is predicted to be around 10.1% from 2025 to 2035, highlighting its robust growth prospects.

Europe is anticipated to hold a significant share of the bioresorbable medical material market as well, accounting for approximately 30% of the total market in 2025. The region's emphasis on sustainability and eco-friendly medical solutions is driving the adoption of bioresorbable materials across various healthcare applications. Additionally, the increasing number of surgical procedures and a growing aging population are contributing to the demand for innovative medical devices in Europe. The European market is projected to grow at a CAGR of 9.8% during the forecast period, supported by ongoing advancements in medical technology and a favorable regulatory environment for bioresorbable products.

Opportunities

The bioresorbable medical material market presents numerous opportunities for growth, particularly as healthcare providers increasingly recognize the benefits of using biodegradable alternatives to traditional materials. One significant opportunity lies in the rising trend of personalized medicine, where bioresorbable materials can be tailored to meet the specific needs of individual patients. This customization can lead to improved treatment outcomes and enhanced patient satisfaction. Furthermore, the increasing focus on sustainability and environmental responsibility in healthcare will drive demand for bioresorbable materials, as these options align with the global movement toward reducing waste and utilizing renewable resources. As more healthcare organizations seek to adopt sustainable practices, the bioresorbable market is well-positioned for growth.

Moreover, advancements in research and development are creating fresh opportunities for innovation in the bioresorbable medical material sector. Ongoing studies and clinical trials are likely to lead to the introduction of new bioresorbable products and formulations that exhibit improved performance in various medical applications. Additionally, the emergence of new technologies, such as 3D printing, is opening avenues for creating customized bioresorbable implants and scaffolds that meet the specific anatomical requirements of patients. As the demand for advanced healthcare solutions continues to rise, the bioresorbable medical material market is poised to capitalize on these opportunities and expand its reach in the industry.

Threats

Despite the promising growth of the bioresorbable medical material market, certain threats are associated with its development and adoption. One of the primary concerns is the potential for adverse reactions among patients, which may arise from the use of bioresorbable materials in various medical procedures. Although these materials are designed to be biocompatible, individual patient responses can vary, and any complications may hinder the acceptance and utilization of these products in clinical settings. Additionally, the stringent regulatory landscape surrounding the approval of medical materials may pose challenges for manufacturers aiming to introduce new bioresorbable products to the market. Navigating the complexities of regulatory compliance can lead to increased costs and longer timelines for product development.

Another threat to the bioresorbable medical material market is the competitive landscape characterized by numerous established players and emerging companies. As the market becomes more crowded, maintaining a competitive edge may require substantial investments in research and development, marketing strategies, and customer engagement initiatives. Companies may face price pressures and the need to differentiate their products to capture market share. The potential for technological advancements and innovations from competitors could also disrupt the current market dynamics, making it essential for bioresorbable material manufacturers to stay ahead of industry trends and continuously adapt their offerings.

Competitor Outlook

• BioTime, Inc.
• Corline Biomedical AB
• Tepha, Inc.
• Zimmer Biomet Holdings, Inc.
• Medtronic plc
• DePuy Synthes (a subsidiary of Johnson & Johnson)
• Abbott Laboratories
• Boston Scientific Corporation
• Polymer Solutions Group
• Stryker Corporation
• KLS Martin Group
• Regenerys
• Smith & Nephew plc
• Akron Biotech
• Fidia Farmaceutici S.p.A.

The competitive landscape of the bioresorbable medical material market is characterized by a diverse array of companies, ranging from established industry leaders to innovative startups. Major players such as Medtronic, Johnson & Johnson, and Stryker are actively engaged in research and development to expand their product portfolios and enhance their market presence. These companies are leveraging their extensive resources, expertise, and distribution networks to gain a competitive advantage in the rapidly evolving healthcare landscape. Furthermore, strategic partnerships and collaborations with research institutions and other organizations are common strategies employed by these players to drive innovation and accelerate product development.

Moreover, emerging companies like Tepha and BioTime are focusing on niche applications within the bioresorbable materials space, developing specialized products that cater to specific medical needs. These companies often prioritize agility and innovation, allowing them to quickly adapt to changing market demands and capitalize on new opportunities. As the market for bioresorbable materials continues to grow, the rivalry among competitors is expected to intensify, prompting companies to focus on differentiation through product quality, performance, and regulatory compliance.

As the bioresorbable medical material market evolves, it is crucial for companies to stay abreast of technological advancements and emerging trends. Key players are likely to invest in cutting-edge research to develop next-generation bioresorbable materials that offer improved performance and expanded applications. Additionally, an increasing emphasis on sustainability in healthcare is driving companies to prioritize eco-friendly production methods and materials. The ability to adapt to industry trends and meet regulatory requirements will be essential for companies looking to establish and maintain a leading position in the bioresorbable medical material market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Regenerys
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Tepha, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Akron Biotech
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 BioTime, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 KLS Martin Group
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smith & Nephew plc
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Corline Biomedical AB
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Polymer Solutions Group
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Fidia Farmaceutici S.p.A.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Zimmer Biomet Holdings, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 DePuy Synthes (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bioresorbable Medical Material Sales Market, By Form
    • 6.1.1 Fibers
    • 6.1.2 Films
    • 6.1.3 Sponges
    • 6.1.4 Meshes
    • 6.1.5 Others
  • 6.2 Bioresorbable Medical Material Sales Market, By User
    • 6.2.1 Hospitals
    • 6.2.2 Ambulatory Surgical Centers
    • 6.2.3 Specialty Clinics
    • 6.2.4 Others
  • 6.3 Bioresorbable Medical Material Sales Market, By Application
    • 6.3.1 Orthopedic
    • 6.3.2 Dental
    • 6.3.3 Cardiovascular
    • 6.3.4 Tissue Engineering
    • 6.3.5 Others
  • 6.4 Bioresorbable Medical Material Sales Market, By Product Type
    • 6.4.1 Polylactic Acid
    • 6.4.2 Polyglycolic Acid
    • 6.4.3 Polycaprolactone
    • 6.4.4 Calcium Phosphate
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Bioresorbable Medical Material Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bioresorbable Medical Material Sales market is categorized based on

By Product Type

• Polylactic Acid
• Polyglycolic Acid
• Polycaprolactone
• Calcium Phosphate
• Others

By Application

• Orthopedic
• Dental
• Cardiovascular
• Tissue Engineering
• Others

By User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Form

• Fibers
• Films
• Sponges
• Meshes
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BioTime, Inc.
• Corline Biomedical AB
• Tepha, Inc.
• Zimmer Biomet Holdings, Inc.
• Medtronic plc
• DePuy Synthes (a subsidiary of Johnson & Johnson)
• Abbott Laboratories
• Boston Scientific Corporation
• Polymer Solutions Group
• Stryker Corporation
• KLS Martin Group
• Regenerys
• Smith & Nephew plc
• Akron Biotech
• Fidia Farmaceutici S.p.A.